Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

NCT00250068 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00250068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00250068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Lead sponsor
University of New Mexico
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
December 31, 2007
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, lung diseases